Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>
Сохранить в:
| Главный автор: | Subhamoy Chakraborty (16648124) (author) |
|---|---|
| Другие авторы: | Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author) |
| Опубликовано: |
2025
|
| Предметы: | |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
по: Subhamoy Chakraborty (16648124)
Опубликовано: (2025) -
Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
по: Subhamoy Chakraborty (16648124)
Опубликовано: (2025) -
Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
по: Subhamoy Chakraborty (16648124)
Опубликовано: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection of cell-free virions.
по: Xiaojuan Li (351842)
Опубликовано: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection and cell-contact mediated viral infection.
по: Xiaojuan Li (351842)
Опубликовано: (2025)